UBS has maintained a "Neutral" rating for British American Tobacco (BAT) with a target price of 3000 Pence, following a recent interim report. Analyst Faham Baig anticipates an improvement in the tobacco company's situation next year, although his forecast for the 2025 operating profit growth is below the analyst consensus.
UBS has maintained a "Neutral" rating for British American Tobacco (BAT) with a target price of 3000 pence, following an interim report. Analyst Faham Baig anticipates an improvement in the company's situation over the next year, although his earnings estimates for 2025 remain below the analyst consensus.
UBS has maintained a 'Neutral' rating for British American Tobacco (BAT) with a target price of 3000 pence, following an interim report. Analyst Faham Baig anticipates an improvement in the tobacco company's situation over the next year, although his earnings estimates for 2025 are below the analyst consensus. As of the latest trading, BAT shares are priced at €36.14, reflecting a 0.89% increase.
UBS has increased its target price for British American Tobacco (BAT) from 2800 to 3000 pence while maintaining a "Neutral" rating. Analyst Faham Baig noted the positive impact of recent investments showcased at the company's capital markets day, although the dynamic market environment may reignite discussions about reducing its stake in ITC.
UBS has raised its target price for British American Tobacco (BAT) from 2800 to 3000 pence while maintaining a "Neutral" rating. Analyst Faham Baig noted the positive impact of recent investments showcased at the company's capital markets day, although the dynamic market environment may prompt discussions about reducing its stake in ITC.
UBS has increased its target price for British American Tobacco (BAT) from 2800 to 3000 pence while maintaining a "Neutral" rating. Analyst Faham Baig noted the positive impact of recent investments showcased at the company's capital markets day, although the dynamic market environment may reignite discussions about reducing its stake in ITC.
UBS has increased its target price for British American Tobacco (BAT) from 2800 to 3000 pence while maintaining a "Neutral" rating. Analyst Faham Baig noted the positive impact of recent investments showcased at the company's capital markets day, although the dynamic market environment may reignite discussions about reducing its stake in ITC.
UBS has maintained a "Neutral" rating for British American Tobacco (BAT) with a target price of 2800 pence following the recent Capital Markets Day. Analyst Faham Baig noted that BAT has reaffirmed its medium-term financial targets, showcasing progress and confidence in its ability to deliver.
UBS has maintained a "Neutral" rating for British American Tobacco (BAT) with a target price of 2800 pence following the company's recent capital markets day. Analyst Faham Baig noted that BAT has reaffirmed its medium-term financial targets, showcasing progress and confidence in its ability to deliver.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
